英文名稱 Anti-CD15/Fut4/SSEA-1

中文名稱 階段特異性胚胎表面抗原-1抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 細(xì)胞膜受體

蛋白分子量 predicted molecular weight: 49kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanCD15 （251-295aa）

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 3-FAL; Alpha (1,3) fucosyltransferase; Alpha 13fucosyltransferase FucT; EC 2.4.1.; ELAM 1ligand fucosyltransferase; ELAM ligand fucosyltransferase; ELAM1 ligandfucosyltransferase; ELFT; FCT3A; Fuc TIV; Fucosyltransferase 4 alpha 1 3fucosyltransferase myeloid specific; Fucosyltransferase 4; FucT IV; FUCTIV;FUT4; Galactoside 3 L fucosyltransferase; Lewis X; LeX; SSEA 1; SSEA1; Stagespecific embryonic antigen 1.